Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

PRC member affects blood formation during aging

Aug. 10, 2020

Keros completes dosing of planned cohorts in phase I study of KER-047

Aug. 6, 2020

Novel humanized platelet mouse model predicts efficacy of experimental antiplatelet drugs

Aug. 5, 2020

Data presented for factor XIa inhibitor milvexian in thrombosis models

Aug. 4, 2020

Src SH3 domain: an antithrombotic target without compromising homeostasis

July 31, 2020

Novel mouse model of AAA with intraluminal thrombus

July 30, 2020

INSERM presents preclinical data for single-domain antibody PS-003

July 28, 2020

FRSW-107 demonstrates extended half-life in patients with hemophilia A

July 28, 2020

FDA allows initiation of clinical trials for desidustat in chemotherapy-induced anemia

July 27, 2020

Discovery and preclinical evaluation of novel direct FXIa inhibitor, ONO-1600586

July 27, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...